Bristol-Myers quarterly profit beats forecasts
January 27, 2015 at 07:56 AM EST
Jan 27 (Reuters) - Bristol-Myers Squibb Co reported higher-than-expected quarterly earnings, helped by surprisingly strong sales of its hepatitis C drugs and its Eliquis blood clot preventer.
